Rôle des lymphocytes Th1 et Th2 dans la physiopathologie des maladies auto-immunes à médiation cellulaire

Aubourg, 1995, Vers de nouvelles approches thérapeutiques, Médecine thérapeutique, 6, 579 Baker, 1995, Genetic analysis of experimental allergic encephalomyelitis in mice, J Immunol, 155, 4046, 10.4049/jimmunol.155.8.4046 Baron, 1993, Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma, J Exp Med, 177, 57, 10.1084/jem.177.1.57 Beck, 1988, Increased production of Interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis, Acta Neurol Scand, 78, 318, 10.1111/j.1600-0404.1988.tb03663.x Bendelac, 1995, CD1, presenting unusual antigens to unusual T lymphocytes, Science, 269, 185, 10.1126/science.7542402 Bergman, 1994, Isletspecific T-cell clones from the NOD mouse respond to β-granule antigen, Diabetes, 43, 197, 10.2337/diabetes.43.2.197 Billiau, 1988, Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFNγ, J Immunol, 140, 1506, 10.4049/jimmunol.140.5.1506 Boissier, 1995, Biphasic effect of interferon-γ in murine collagen-induced arthritis, Eur J Immunol, 25, 1184, 10.1002/eji.1830250508 Brocke, 1993, Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen, Nature, 365, 642, 10.1038/365642a0 Brocke, 1996, Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein, Nature, 379, 343, 10.1038/379343a0 Campbell, 1991, Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice, J Clin Invest, 87, 739, 10.1172/JCI115055 Cash, 1994, Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats, J Immunol, 152, 4258, 10.4049/jimmunol.153.9.4258 Chen, 1994, Regulatory T cell clones induced by oral tolerance, suppression of autoimmune encephalomyelitis, Science, 265, 1237, 10.1126/science.7520605 Cogan, 1994, Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome, N Engl J Med, 330, 535, 10.1056/NEJM199402243300804 Constant, 1995, Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells, J Exp Med, 182, 1591, 10.1084/jem.182.5.1591 Cross, 1994, Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice, J Clin Invest, 93, 2684, 10.1172/JCI117282 Cua, 1995, Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE) -resistant mice, J Immunol, 155, 4052, 10.4049/jimmunol.155.8.4052 Daniel, 1995, Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice, Eur J Immunol, 25, 1056, 10.1002/eji.1830250430 Debray-Sachs, 1991, Prevention of diabetes in NOD mice treated with antibody to murine IFNγ, J Autoimmunity, 4, 237, 10.1016/0896-8411(91)90021-4 Duong, 1992, Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse, J Neuroimmunol, 36, 105, 10.1016/0165-5728(92)90042-J Elliott, 1994, Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis, Lancet, 344, 1105, 10.1016/S0140-6736(94)90628-9 Fabry, 1994, Nervous tissue as an immune compartment, the dialect of the immune response in the CNS, Immunol Today, 15, 218, 10.1016/0167-5699(94)90247-X Feldmann, 1996, Rheumatoid arthritis, Cell, 85, 307, 10.1016/S0092-8674(00)81109-5 Ferrick, 1995, Differential production of interferon-γ and interleukin-4 in response to Th1-and Th2-stimulating pathogens by γβ T cells in vivo, Nature, 373, 255, 10.1038/373255a0 Forsthuber, 1996, Induction of Th1 and Th2 immunity in neonatal mice, Science, 271, 1728, 10.1126/science.271.5256.1728 Fowell, 1993, Evidence that the T cell repertoire of normal rats contains cell with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential, J Exp Med, 177, 627, 10.1084/jem.177.3.627 Gajewski, 1991, Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations, J Immunol, 146, 1750, 10.4049/jimmunol.146.6.1750 Germann, 1995, Administration of interleukin-12 in combination with type II collagen induces severe arthritis in DBA/1 mice, 92, 4823 Goldman, 1991, Th2 cells in systemic autoimmunity, Immunol Today, 12, 223, 10.1016/0167-5699(91)90034-Q Guery, 1996, Selective development of T helper (Th2) cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice, J Exp Med, 183, 485, 10.1084/jem.183.2.485 Güler, 1996, Genetic susceptibility to Leishmania, IL-12 responsiveness in Th1 cell development, Science, 271, 984, 10.1126/science.271.5251.984 Harrison, 1993, Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulindependent diabetes, Lancet, 341, 1365, 10.1016/0140-6736(93)90940-I Healey, 1995, In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice, J Clin Invest, 95, 2979, 10.1172/JCI118006 Herold, 1996, Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin, J Immunol, 156, 3521, 10.4049/jimmunol.156.9.3521 Hosken, 1995, The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model, J Exp Med, 182, 1579, 10.1084/jem.182.5.1579 Hsieh, 1992, Differential regulation of T helper phenotype development by interleukins-4 and 10 in an αβ T-cell-receptor transgenic system, 89, 6065 Hsieh, 1992, Development of Th CD4+ T cells through IL-12 produced by Listeria-induced macrophages, Science, 260, 547, 10.1126/science.8097338 Huang, 1995, Interferon expression in the pancreases of patients with type 1 diabetes, Diabetes, 44, 658, 10.2337/diabetes.44.6.658 Karin, 1994, Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope, T cell receptor antagonism and reduction of interferon-γ and tumor necrosis factor α production, J Exp Med, 180, 2227, 10.1084/jem.180.6.2227 Karpus, 1992, CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion, Eur J Immunol, 22, 1757, 10.1002/eji.1830220714 Katsikis, 1994, Immunoregulatory role of interleukin 10 in rheumatoid arthritis, J Exp Med, 179, 1517, 10.1084/jem.179.5.1517 Katz, 1995, T helper cell subsets in insulin-dependent diabetes, Science, 268, 1185, 10.1126/science.7761837 Keffer, 1991, Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis, EMBO J, 10, 4025, 10.1002/j.1460-2075.1991.tb04978.x Kennedy, 1992, Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery, J Immunol, 149, 2496, 10.4049/jimmunol.149.7.2496 Khoury, 1992, J Exp Med, 176, 1355, 10.1084/jem.176.5.1355 Kopf, 1993, Disruption of the murine IL-4 gene blocks Th2 cytokine responses, Nature, 362, 245, 10.1038/362245a0 Kuchroo, 1995, B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways, application to autoimmune disease therapy, Cell, 80, 707, 10.1016/0092-8674(95)90349-6 Kühn, 1991, Generation and analysis of interleukin-4 deficient mice, Science, 254, 707, 10.1126/science.1948049 Lamont, 1996, IL-12, a key cytokine in immune regulation, Immunol Today, 17, 214, 10.1016/0167-5699(96)30011-X Leonard, 1995, Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12, J Exp Med, 181, 381, 10.1084/jem.181.1.381 Liblau, 1995, Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases, Immunol Today, 16, 34, 10.1016/0167-5699(95)80068-9 Liblau, 1992, Encéphalomyélite allergique expé- rimentale Locksley, 1991, Helper T-cell subsets in mouse leishmaniasis, induction, expansion and effector function, Immunol Today, 12, A58, 10.1016/S0167-5699(05)80017-9 Lorente, 1995, Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus, J Exp Med, 181, 839, 10.1084/jem.181.3.839 MacMicking, 1992, Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells, J Exp Med, 176, 303, 10.1084/jem.176.1.303 Magram, 1996, IL-12-deficient mice are defective in IFNγ production and type 1 cytokine responses, Immunity, 4, 471, 10.1016/S1074-7613(00)80413-6 Malotky, 1993, Differential recognition of sequences within the encephalitogenic region of myelin basic protein capable of eliciting cell-mediated immune responses in experimental autoimmune encephalomyelitis, J Neuroimmunol, 48, 135, 10.1016/0165-5728(93)90185-2 Marcelletti, 1991, Collagen-induced arthritis in mice, J Immunol, 147, 4185, 10.4049/jimmunol.147.12.4185 Merrill, 1993, Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide, J Immunol, 151, 2132, 10.4049/jimmunol.151.4.2132 Merrill, 1992, Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice, 89, 574 Miller, 1994, The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases, Immunol Today, 15, 356, 10.1016/0167-5699(94)90173-2 Moritani, 1994, Transgenic expression of IL-10 in pancreatic islet cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice, Intern Immunol, 12, 1927, 10.1093/intimm/6.12.1927 Mosmann, 1986, Two types of murine helper T cell clone, J Immunol, 136, 2348, 10.4049/jimmunol.136.7.2348 Murray, 1992, Major histocompatibility complex (MHC) control of CD4 T cell subset activation. II. A single peptide induces either humoral or cell-mediated responses in mice of distinct MHC genotype, Eur J Immunol, 22, 559, 10.1002/eji.1830220239 Mustafa, 1994, Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles, J Immunol, 153, 3337, 10.4049/jimmunol.153.7.3337 Myers, 1993, A synthetic peptide analogue of a determinant of type II collagen prevents the onset of collagen-induced arthritis, J Immunol, 150, 4652, 10.4049/jimmunol.150.10.4652 Nicholson, 1995, An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis, Immunity, 3, 397, 10.1016/1074-7613(95)90169-8 O'Garra, 1994, Roles of cytokines in determininig T lymphocyte function, Curr Opin Immunol, 6, 458, 10.1016/0952-7915(94)90128-7 Okamura, 1995, Cloning of a new cytokine that induces INF-γ production by T cells, Nature, 378, 88, 10.1038/378088a0 Olsson, 1995, Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis, Immunol Rev, 144, 245, 10.1111/j.1600-065X.1995.tb00072.x Opdenakker, 1994, Cytokine-regulated proteases in autoimmune diseases, Immunol Today, 15, 103, 10.1016/0167-5699(94)90151-1 Openshaw, 1995, Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations, J Exp Med, 182, 1357, 10.1084/jem.182.5.1357 Panitch, 1987, Treatment of multiple sclerosis with gamma Interferon, exacerbations, associated with activation of the immune system, Neurology, 37, 1097, 10.1212/WNL.37.7.1097 Parish, 1972, The relationship between humoral and cell-mediated immunity, Transplant Rev, 13, 35 Paul, 1994, Lymphocyte response and cytokines, Cell, 76, 241, 10.1016/0092-8674(94)90332-8 Pennline, 1994, Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse, Clin Immunol Immunopathol, 71, 169, 10.1006/clin.1994.1068 Perez, 1995, Stability of Th1 and Th2 populations, Intern Immunol, 5, 869, 10.1093/intimm/7.5.869 Rabinovitch, 1995, IFNγ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice, J Immunol, 154, 4874, 10.4049/jimmunol.154.9.4874 Racke, 1994, Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease, J Exp Med, 180, 1961, 10.1084/jem.180.5.1961 Rapoport, 1993, Interleukin-4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice, J Exp Med, 178, 87, 10.1084/jem.178.1.87 Röcken, 1996, IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease, Immunol Today, 17, 225, 10.1016/0167-5699(96)80556-1 Romagnani, 1991, Human Th1 and Th2 subsets, doubt no more, Immunol Today, 12, 257, 10.1016/0167-5699(91)90120-I Rott, 1994, Interleukin-10 prevents experimental allergic encephalomyelitis in rats, Eur J Immunol, 24, 1434, 10.1002/eji.1830240629 Ruddle, 1990, An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis, J Exp Med, 172, 1193, 10.1084/jem.172.4.1193 Sad, 1995, Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines, Immunity, 2, 271, 10.1016/1074-7613(95)90051-9 Saoudi, 1995, Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells, evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells, J Exp Med, 182, 335, 10.1084/jem.182.2.335 Sarvetnick, 1990, Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ, Nature, 346, 844, 10.1038/346844a0 Scott, 1994, A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity, Immunity, 1, 73, 10.1016/1074-7613(94)90011-6 Secrist, 1993, Allergenic immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals, J Exp Med, 178, 2123, 10.1084/jem.178.6.2123 Secrist, 1995, Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type, J Exp Med, 181, 1081, 10.1084/jem.181.3.1081 Seder, 1995, The functional role of CD8+ T helper type 2 cells, J Exp Med, 181, 5, 10.1084/jem.181.1.5 Seder, 1992, The presence of interleukin-4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice, J Exp Med, 176, 1091, 10.1084/jem.176.4.1091 Selmaj, 1991, Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions, J Clin Invest, 87, 949, 10.1172/JCI115102 Sharief, 1991, Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis, N Engl J Med, 325, 467, 10.1056/NEJM199108153250704 Shehadeh, 1993, Altered cytokine activity in adjuvant inhibition of autoimmune diabetes, J Autoimmunity, 6, 291, 10.1006/jaut.1993.1025 Simon, 1994, Divergent T-cell cytokine patterns in inflammatory arthritis, 91, 8562 Sommer, 1995, The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis, Nature Med, 3, 244, 10.1038/nm0395-244 Stüber, 1996, Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin-12 secretion, J Exp Med, 183, 693, 10.1084/jem.183.2.693 Swain, 1994, Generation and in vivo persistence of polarized Th1 and Th2 memory cells, Immunity, 1, 543, 10.1016/1074-7613(94)90044-2 Tchélingérian, 1995, Differential oligodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro, J Neurochem, 65, 2377, 10.1046/j.1471-4159.1995.65052377.x Thorbecke, 1992, Involvement of endogenous tumor necrosis factor a and transforming growth factor β during induction of collagen type II arthritis in mice, 89, 7375 Tian, 1996, Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes, J Exp Med, 183, 1561, 10.1084/jem.183.4.1561 Tisch, 1996, Insulindependent diabetes mellitus, Cell, 85, 291, 10.1016/S0092-8674(00)81106-X Tisch, 1993, Immune response to glutamic acid decarboxylase correlates with insulitis in nonobese diabetic mice, Nature, 366, 72, 10.1038/366072a0 Traugott, 1988, Multiple sclerosis, involvement of interferons in lesion pathogenesis, Ann Neurol, 24, 243, 10.1002/ana.410240211 Trembleau, 1995, Interleukin-12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice, J Exp Med, 181, 817, 10.1084/jem.181.2.817 Wogensen, 1994, Production of interleukin-10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice, J Exp Med, 179, 1379, 10.1084/jem.179.4.1379 Yu, 1994, Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type I diabetes, Diabetes, 43, 1229, 10.2337/diabetes.43.10.1229